Fife, United Kingdom

Daniella I Zheleva

USPTO Granted Patents = 4 


Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Fife, GB (2011 - 2013)
  • Dundee, GB (2008 - 2018)

Company Filing History:


Years Active: 2008-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Daniella I Zheleva: Innovator in Pharmaceutical Research

Introduction

Daniella I Zheleva is a prominent inventor based in Fife, GB. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatment methods for various disorders. With a total of four patents to her name, her work has the potential to impact the medical community significantly.

Latest Patents

Daniella's latest patents include a method for treating proliferative disorders using sapacitabine and seliciclib. This invention outlines a specific dosage regimen that involves administering these compounds in a structured manner over multiple treatment cycles. Additionally, she has developed pyrimidin-4-yl-3, 4-dihydro-2H-pyrrolo [1,2A] pyrazin-1-one compounds, which are designed for use in pharmaceutical compositions aimed at treating a variety of disorders, including viral infections and strokes.

Career Highlights

Daniella works at Cyclacel Limited, where she continues to advance her research and development efforts. Her innovative approaches to drug formulation and treatment regimens have garnered attention in the pharmaceutical industry.

Collaborations

Daniella collaborates with notable colleagues, including Peter Martin Fischer and Kenneth Duncan, to further enhance her research initiatives and drive innovation in the field.

Conclusion

Daniella I Zheleva is a trailblazer in pharmaceutical innovation, with a focus on developing effective treatment methods for serious health conditions. Her contributions are paving the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…